15 results
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
information regarding our clinical trial subjects or employees, could harm our reputation directly, compel us to comply with federal and/or state … , if approved;
decreased demand for our products;
injury to our reputation;
withdrawal of clinical trial participants and inability to continue
10-Q
2023 Q2
TSBX
Turnstone Biologics Corp
1 Sep 23
Quarterly report
4:39pm
, including personal information regarding our clinical trial subjects or employees, could harm our reputation directly, compel us to comply with federal … to the market, if approved;
decreased demand for our products;
injury to our reputation;
withdrawal of clinical trial participants and inability
424B4
TSBX
Turnstone Biologics Corp
21 Jul 23
Prospectus supplement with pricing info
7:14pm
harm our reputation directly, compel us to comply with federal and/or state breach notification laws and foreign law equivalents, subject us … reputation;
withdrawal of clinical trial participants and inability to continue clinical trials;
initiation of investigations by U.S. and foreign
S-1/A
pzqmqtgpvwxjx3efc
23 Jun 23
IPO registration (amended)
9:49pm
S-1
EX-2.1
gmziehlw85b0
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.9
4mmhcbargt
12 Jun 23
IPO registration
4:28pm
S-1
i9lpads8u06axa8l
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.10
k6oa25
12 Jun 23
IPO registration
4:28pm
DRS
EX-10.10
lfrrdx8ym qov3iaizi8
15 May 23
Draft registration statement
12:00am
DRS
EX-10.9
v9h bpc6by81w2g18dfv
15 May 23
Draft registration statement
12:00am
DRS
EX-2.1
dok0xa8zr fimiifb
15 May 23
Draft registration statement
12:00am
DRS
chlcyl5p
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next